Continuous Positive Airway Pressure (CPAP) devices will be coming to NYS EMT's shortly. Here is a short guide to CPAP. Since we do not know yet how the NYS BLS Protocols will permit EMTs to use CPAP we will keep it very general for now. It will obviously be used in Acute Pulmonary Edema, but it is unclear if it will be allowed in other emergency situation.
Before we start just remember that CPAP cannot be used in any patient with any of the following conditions EVEN if they are in respiratory distress:
1. Decreased Mental Status / Inability to sit up / Altered Mental Status
2. Respiratory arrest / Apnea / Respiratory failure / poor inspiratory effort
3. Pneumothorax / Trauma to the thorax / Subcutaneous Emphysema
4. Any form of Shock / Hypotension
5. Nausea / Vomiting / any risk of aspiration
6. Facial Trauma / Abnormalities
How CPAP Works:
Continuous Positive Airway Pressure, (CPAP), is the
maintenance of positive pressure throughout the complete respiratory cycle,
(inspiration and expiration), when breathing spontaneously. CPAP is not the
same as Positive End Expiratory Pressure or PEEP. PEEP only provides pressure
on the expiratory side by offering resistance to exhalation using a
spring-loaded valve or air flow.
1. During the inspiratory phase, patients in distress will have to create
a higher flow rate of air to meet their needs, this will present as an increase
in work-of-breathing (WOB). Patients in respiratory distress may need to
achieve inspiratory flow rates greater than 65 liters per min (LPM). With the
inspiratory support of CPAP, the patient does not have to work as hard to
inhale and overcoming the auto PEEP in the lung. Auto-PEEP represents the
abnormal, and usually undetected, residual pressure above atmospheric remaining
in the alveoli at end-exhalation due to air trapping. The auto PEEP has to be overcome each time a
person inhales, for a healthy person the work is minimal and goes unnoticed.
However, those patients with stiff lungs, (CHF and Pulmonary Fibrosis), have to
work extremely hard to overcome the increased auto PEEP on every breath.
2. The increased inspiratory pressure also increases the size, therefore
the surface area of the
alveoli, providing a greater opportunity for gas exchange or respiration.
The process increases the
Functional Residual Capacity (FRC) of the lung. The FRC is the area where
gas exchange takes place.
3. Since a greater oxygen percentage is able to reach the alveoli during
CPAP, the partial pressure
of the oxygen molecule will be greater. The higher partial pressure will
allow more oxygen to
diffuse into the blood stream improving oxygenation.
4. Fluid in the alveolar space cannot only make the lung stiff,
(increasing inspiratory
work-of-breathing), it also creates a barrier that can reduce gas
exchange. The pressure from CPAP
can reduce the fluid by forcing fluid out of the alveolar space back into
the interstitium.
5. During the expiratory phase, the patient will breathe against a
threshold of resistance that
works as a pneumatic splint to hold the airways open. Patients with
chronic lung disease have
weakened airways that have a tendency to collapse on expiration, causing
air trapping. Having the
airways stinted open during exhalation will make inspiration on the next
breath less difficult.
6. The resistance during exhalation can open non-ventilated areas of the
lung recruiting alveoli
that have collapsed due to atelectasis, (a collapse of lung tissue
affecting part, or all, of one
lung effecting gas exchange).
7. CPAP decreases pre-load and after-load on the heart reducing the
heart’s workload. However, a reduction in pre-load and after-load will have an
effect on the patient’s blood pressure. Patients
should have a systolic blood pressure of at least 100 mmHg before
starting CPAP.
What Types of Patients Are NOT Candidates for CPAP?
CPAP and Congestive Heart Failure (CHF):
The treatment of Congestive Heart Failure, (CHF), by EMS has changed significantly in the last couple of years. The mainstays of CHF treatment (ALS) in the pre-hospital setting are CPAP and nitroglycerin. The efficacy of Lasix and Morphine is under scrutiny and has been removed from many EMS ALS protocols. Many systems that adopt CPAP start with CHF. The effects of CPAP are well suited for the physiologic issues associated with this disease. Pulmonary edema, associated with CHF, makes the lungs stiff and it is difficult for the patient to inhale; and can be observed as difficulty breathing during the inspiratory phase of ventilation or inspiratory shortness-of-breath. Since CHF is primarily a heart problem, CPAP addresses the side effects of a failing heart and its impact on the lungs. CHF is a process that will continue to spiral down the cardiogenic shock pathway until the cycle is broken. As the patient’s heart fails, more fluid ends up in the lungs. With more fluid in the lungs, less oxygen makes it to the heart muscle, so the heart fails even more. The first step in stopping the cycle is the early use of CPAP. If the patient does not have lung disease then the airways should function normally and not collapse on exhalation. In this case, the inspiratory pressure will force the fluid out of the lungs, expand the alveoli which, in turn, will increase gas exchange (respirations) improving oxygenation.In addition, with the airways being held open by the expiratory resistance, the patient does not have to overcome
the auto PEEP at the beginning of each breath. With the improvement of gas exchange and reduced impact of auto PEEP, the patient’s work-of-breathing will be reduced. With the reduced work, there will be less stress on the heart. A key factor in the initiation of CPAP is the patient’s blood pressure. It is recommended that the systolic blood pressure be at least 100 mmHg before starting CPAP due to the reduction in pre-load and after-load.
More to come after the protocols are released.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.